ICU antibiotic dosing under scrutiny: are patients on ECMO getting enough?
NCT ID NCT07287813
First seen Jan 05, 2026 · Last updated May 15, 2026 · Updated 16 times
Summary
This study looks at whether the usual doses of certain strong antibiotics are right for critically ill patients who are on ECMO (heart-lung support) or dialysis. The goal is to make sure the drugs reach levels that kill bacteria without being toxic. About 40 adults in the ICU with gram-negative infections will be monitored to improve future dosing guidelines.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ICU PATIENTS WITH ECMO AND-OR RRT AND WITH GRAM NEGATIVE INFECTIONS SUSCEPTIBLE TO BL-BLIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fondazione IRCCS Policlinico San Matteo
Pavia, Lombardy, 27100, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.